Clinical Trials Browser

Phase 2 × Squamous Cell Carcinoma of Head and Neck × Panitumumab × Clear all

NCT05423197 2025-07-16

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT00756444 2018-11-15

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

67 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT01305772 2014-08-29

TOP0901

Phase 2 Terminated

6 enrolled 6 charts

Squamous Cell Carcinoma of Head and Neck